DBVT Q4 2018 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+123.5% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$56M-1299.8% margin

Net Income

-$56M-1295.2% margin

EPS (Diluted)

$-6.05

QoQ Revenue Growth

+43.8%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$41M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$235M

Total Liabilities

$69M

Stockholders' Equity

$166M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+123.5%
Gross Profit	$4M	$2M	+123.5%
Operating Income	-$56M	-$44M	-25.9%
Net Income	-$56M	-$45M	-23.3%